Emerging strategies in the diagnosis, prevention and treatment of chlamydial infections

Bibliography

• FUKUSHI H, HIRAI K: Proposal for Chlarnydia pecorum sp. nov. for Chlamydia strains derived from ruminants. Int. j Syst. Bart. (1992) 42:306–308.
   Google Scholar
• FUKUSHI H, HIRAI K: Restriction fragment length polymorphisms of rRNA as genetic markers to differentiate Chlamydia spp. Int.j Syst. Bart. (1993) 43:613–617.
   PubMedGoogle Scholar
• EVERETT KDE, BUSH RM, ANDERSEN AA: Emended description of the order Chlamydiales, proposal of Parachlamydiacea fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int. I Syst. Bart. (1999) 49:415–440.
   Google Scholar
• •New taxonomic scheme for the order Chlamydiales.
   Google Scholar
• WANG S-P, GRAYSTON JT: Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. I Ophthal (1970) 70:367–374.
   PubMedGoogle Scholar
• SCHACHTER J, DAWSON CR: The epidemiology of trachoma predicts more blindness in the future. Scant/. I Exp. Med. (1990) 181:137–149.
   Google Scholar
• HOBSON D, REES E, VISWALINGAMN: Chlamydial infections in neonates and older children. Br Med. Bull. (1983) 39:128–132.
   PubMed Web of Science ®Google Scholar
• KUO C-C, WANG S-P, HOLMES la, GRAYSTON JT: Immunotypes of Chlamydia trachomatis in Seattle, Washington. Infect. Immun. (1983) 41:865–868.
   PubMedGoogle Scholar
• LAGA M: Epidemiology and control of sexually transmitted diseases in developing countries. Sex. Trans. Dis. (1993):S45–S50.
   Google Scholar
• STAMM WE: Chlamydia trachomatis infections of the adult. In: Sexually Transmitted Diseases. Holmes KK, Spalding PF, Mardh PA et al (Ed.), McGraw-Hill Health Professions Division, New York, USA (1999):407–422.
   Google Scholar
• •Summary of efficacies of antimicrobials tested against C. trachomatis genital infections.
   Google Scholar
• SCHACHTER J, DAWSON CR: Human Chlamydial Infections. PSG Publishing Company, Littleton, Massachusetts, USA (1978).
   Google Scholar
• HARRISON HR, ENGLISH MG, LEE CK, ALEXANDER ER: Chlamydia trachomatis infant pneumonitis: comparison with matched controls and other infant pneumonitis. N Engl. j Med. (1978) 298:702–708.
   PubMed Web of Science ®Google Scholar
• BLOCK SL, HAMMERSCHLAG MR, HEDRICK J et al.: Chlamydia prieumoniae in acute otitis media. Fed. Infect. Dis. (1997) 16:858–862.
   PubMedGoogle Scholar
• BAS C, GRIFFAIS R, KVIEN TK et al: Amplification and plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arth. Rheumatol (1995) 38:1005–1013.
   PubMedGoogle Scholar
• SIEPER J, KINGSLEY G: Recent advances in the pathogenesis of reactive arthritis. Immunol Today (1996) 17:160–163.
   PubMedGoogle Scholar
• SCHACHTER J, OSOBA AO: Lymphogranuloma venereum. Br. Med. Bull. (1983) 39:151–154.
   PubMedGoogle Scholar
• BARRON AL, WHITE HJ, RANK RG, SOLOFF BL, MOSES EB: A new animal model for the study of Chiamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. Infect. Dis. (1981) 143:63–66.
   Google Scholar
• GAILLAT J: Clinical manifestations of Chlamydia prieumoniae infections. Revue de Med. Interne (1996) 17:987–991.
   PubMed Web of Science ®Google Scholar
• HAHN DL, DODGE RW, GOLUBJATNIKOV R: Association of Chlamydia prieumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. j Am. Med. Assoc. (1991) 266:225–230.
   PubMed Web of Science ®Google Scholar
• •First study suggesting C. pneumoniae may be involved in the pathology of asthma.
   Google Scholar
• GRAYSTON JT, ALDOUS MB, EASTON A et al.: Evidence that Chlamydia prieumaniae causes pneumonia and bronchitis. J. Infect Dis. (1993) 168:1231–1235.
   PubMed Web of Science ®Google Scholar
• SAIKKU P, LEINONEN M, TENKANEN L et al.: Chronic Chlamydia prieumaniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Int. Med. (1992) 116:273–278.
   PubMed Web of Science ®Google Scholar
• THOM DH, GRAYSTON JT, SISCOVICK DS et al: Association of prior infection with Chlamydia prieumaniae and angiographically demonstrated coronary artery disease. I Am. Med. As.soc. (1992) 268:68–72.
   PubMed Web of Science ®Google Scholar
• BALIN BJ, GERARD HC, ARKING EJ et al.: Identification and localisation of Chlamydiapneumoniae in the Alzheimer's brain. Med. Microbial Immunal (1998) 187:23–42.
   PubMed Web of Science ®Google Scholar
• SRIRAM S, STRATTON CW, YAO S et al.: Chlamydiapneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neural (1999) 46:6–14.
   PubMed Web of Science ®Google Scholar
• SAIKKU P, LEINONEN M, MATTILDA K et al.: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 2:983–985.
   PubMed Web of Science ®Google Scholar
• •This paper (and the following) were the initial reports suggesting that C. pneumoniae may be involved in the pathology of coronary artery disease.
   Google Scholar
• SHOR A, KUO CC, PATTON DL: Detection of Chlarnydia prieumaniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. 1 (1992) 82:158–161.
   PubMed Web of Science ®Google Scholar
• •As above.
   Google Scholar
• GURFINKEL E, BOZOVICH G, DAROCA A, BECK E, MAUTNER B: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet (1997) 350:404–407.
   PubMed Web of Science ®Google Scholar
• GUPTA S, LEATHAM EW, CARRINGTON D, MENDALL MA, KASKI JC, CAMM J: Elevated Chlamydia prieumaniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation (1997) 96:404–407.
   PubMed Web of Science ®Google Scholar
• BACHMAIER K, NEU N, DE LA MAZA LM, PAL S, HESSEL A, PENNINGER JM: Chlamydia infections and heart disease linked through antigenic mimicry. Science (1999) 283:1335–1339.
   PubMed Web of Science ®Google Scholar
• JACKSON M, WHITE N, GIFFARD P, TIMMS P: Epizootiology of Chlamydia infections in two free-range Koala populations. Vet. Microbial (1999) 65:255–264.
   PubMed Web of Science ®Google Scholar
• SCHACHTER J: Evolution of diagnostic tests for Chlamydia trachomatis infections. Proceedings of the 3rd Meeting of the European Socieh, for Chlamydial Research. Vienna, Austria (1996):243–246.
   Google Scholar
• ••This paper (and the following) provide a through review of diagnostic tests for Chlamydia trachomads infections.
   Google Scholar
• SCHACHTER J: Diagnosis of Human Chlamydial Infections. Proceedings of the 9th International Symposium on Human Chlamydial Infection. Napa, California, USA (1998):577–586.
   Google Scholar
• ••As above.
   Google Scholar
• STAMM WE, HOLMES KK: Chlamydia trachomatis infections of the adult. In: Sexually Transmitted Diseases. Holmes KK, Mardh P-A, Sparling PF et al. (Ed.), McGraw-Hill, New York, USA (1984):258–270.
   Google Scholar
• DUNLOP EMC: Chlamydial infection: terminology, disease and treatment. In: Recent advances in sexually transmitted diseases. Harris JRW (Ed.), Churchill Livingstone, Edinburgh, UK (1981):101–119.
   Google Scholar
• ORIEL JD, RIDGWAY CL: Genital infection by Chlamydia trachomatis. Edward Arnold, London, UK (1982).
   Google Scholar
• RAULSTON JE: Pharmacokinetics of azithromycin and erythromycin in human endometrial epithelial cells and in cells infected with Chlamydia trachomatis. Antimicrob. Chemother. (1994) 34:765–776.
   Google Scholar
• LODE H, BORNER K, KOEPPE P, SCHABERG T: Azithromycin - review of key chemical, pharmacokinetic and microbiological features. j Antimicrob. Chemother. (1996) 37(S):C1–C8.
   Google Scholar
• ENGEL JN: Azithromycin-induced block of elementary body formation in Chlamydia trachomatis. Antimicrob. Agents Chemother. (1992) 36:2304–2309.
   PubMedGoogle Scholar
• SCHACHTER J: Rifampin in chlamydial infections. Rev Infect. Dis. (1983) 5:S562–S564.
   Google Scholar
• DE LA MAZA MA, DE LA MAZA LM: A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine (1995) 13:119–127.
   PubMedGoogle Scholar
• •Model showing the advantage of a C. trachomads vaccination program on prevalence of infection.
   Google Scholar
• WANG SP, GRAYSTON JT, ALEXANDER ER: Trachoma vaccine studies in monkeys. Am. I. Ophthal. (1967) 63:1615–1620.
   PubMed Web of Science ®Google Scholar
• •Results from initial chlamydial vaccine studies.
   Google Scholar
• SU H, MESSER R, WHITMIRE W, FISCHER E, PORTIS JC, CALDWELL HD: Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. I. Exp. Med. (1998) 188:809–818.
   PubMedGoogle Scholar
• PAL S, THEODOR I, PETERSON EM, DE LA MAZA LM: Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect. Immun. (1997) 65:3361–3369.
   PubMed Web of Science ®Google Scholar
• MORRISON RP MANNING DS, CALDWELL HD: Immunology of Chlamydia trachomatis infections, immunoprotective responses. In: Sexually Transmitted Diseases. Quinn T (Ed.), Raven Press, New York, USA (1992):57–84.
   Google Scholar
• CALDWELL HD, PERRY LJ: Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect. Immun. (1982) 38:745–754.
   PubMed Web of Science ®Google Scholar
• ZHANG Y-X, STEWART S, JOSEPH T, TAYLOR HR, CALDWELL HD: Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. j Irnmunal. (1987) 138:575–581.
   PubMedGoogle Scholar
• ZHANG YX, STEWART SJ, CALDWELL HD: Protective monoclonal antibodies to Chlamydia trachomatisserovar- and serogroup-specific major outer membrane protein determinants. Infect. Immun. (1989) 57:636–638.
   PubMed Web of Science ®Google Scholar
• QU Z, CHENG X, DE LA MAZA LM, PETERSON EM: Characterization of a neutralising monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars. Infect. brim (1993) 61:1365–1370.
   PubMed Web of Science ®Google Scholar
• COTTER TW, MENG Q, SHEN Z-L, ZHANG Y-X, SU H, CALDWELL HD: Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlarnydia trachomatis genital tract infection. Infect. branurr. (1995) 63:4704–4714.
   PubMed Web of Science ®Google Scholar
• PAL S, THEODOR I, PETERSON EM, DE LA MAZA LM: Monoclonal immunoglobulin A antibody to the major outer membrane protein of Chlarnydia tracharnatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine (1997) 15:575–582.
   PubMed Web of Science ®Google Scholar
• SU H, CALDWELL HD: Immunogenicity of a synthetic oligopeptide corresponding to antigenically common T-helper and B-cell neutralizing epitopes of the major outer membrane protein of Chlarnydia tracharnatis. Vaccine (1993)11:1159–1166.
   PubMedGoogle Scholar
• TUFFREY M, ALEXANDER F, CONLAN W WOODS C, WARD M: Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlarnydia tracharnatis by prior immunization with recombinant serovar Li major outer-membrane protein. j Geri Microbial. (1992) 138:1707–1715.
   PubMedGoogle Scholar
• ZHANG D-J, YANG X, BERRY J et al: DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlarnydia trachomatis (mouse pneumonitis) infection. j Infect. Dis. (1997) 176:1035–1040.
   PubMedGoogle Scholar
• SUKUMAR E BARNHART M, WET Q, ABAI AM, PETERSON EM, DE LA MAZA LM: Vaccination of mice with DNA plasmids coding for the Chlarnydia tracharnatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine (1999) 17:459–465.
   PubMedGoogle Scholar
• SVANHOLM C, BANDHOLTZ L, CASTANOS-VELEZ E, WIGZELL H, ROTTENBERG ME: Protective DNA immunization against Chlarnydia prieurnaniae. Scand. j Inanurial (2000) 51:345–353.
   Google Scholar
• WHITTUM-HUDSON JA, AN L-L, SALTZMAN WM, PRENDERGAST RA, MACDONALD AB: Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlarnydia trachomatis infection. Nat. Med. (1996) 2:1116–1121.
   PubMed Web of Science ®Google Scholar
• RANK RG: Models of immunity. In: Chlarnydia: intracellular biology, pathogenesis and immunity Stephens RS (Ed.), ASM Press, Washington DC, USA (1999):239–295.
   Google Scholar
• STEPHENS RS, KALMAN S, LAMMEL C etal.: Genome sequence of an obligate intracellular pathogen of humans: Chlarnydia tracharnatis. Science (1998) 282:754–759.
   Google Scholar
• ••Genome sequence of C. trachomatis.
   Google Scholar
• MARX R: Social factors and trachoma: a review of the literature. .Sc. Science Med. (1989) 29:23–34.
   PubMed Web of Science ®Google Scholar
• SOMANI J, BHULLAR VB, WORKOWSKI KA, RARSHY CE, BLACK CM: Multiple drug-resistant Chlarnydia trachomatis associated with clinical treatment failure. j Infect. Dis. (2000) 181:1421–1427.
   PubMed Web of Science ®Google Scholar
• IGIETSEME JU, MURDIN A: Induction of protective immunity against Chlarnydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect. Inanturr. (2000) 68:6798–6806.
   Google Scholar